IRIS UniCatt

Torti, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.248
AS - Asia 1.203
EU - Europa 831
SA - Sud America 362
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.681
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.183
SG - Singapore 534
BR - Brasile 294
CN - Cina 292
DE - Germania 161
SE - Svezia 131
VN - Vietnam 122
IT - Italia 108
FR - Francia 93
UA - Ucraina 66
GB - Regno Unito 58
PL - Polonia 54
IN - India 44
IE - Irlanda 43
BD - Bangladesh 40
FI - Finlandia 36
ID - Indonesia 34
AR - Argentina 31
CA - Canada 25
HK - Hong Kong 25
MX - Messico 25
JP - Giappone 24
RU - Federazione Russa 22
KR - Corea 19
EC - Ecuador 15
IQ - Iraq 14
NL - Olanda 14
ZA - Sudafrica 14
TR - Turchia 12
AT - Austria 10
CO - Colombia 6
ES - Italia 6
LT - Lituania 6
UZ - Uzbekistan 6
BE - Belgio 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
EG - Egitto 4
KE - Kenya 4
PH - Filippine 4
PK - Pakistan 4
UY - Uruguay 4
VE - Venezuela 4
CH - Svizzera 3
CL - Cile 3
KG - Kirghizistan 3
PY - Paraguay 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
CR - Costa Rica 2
HN - Honduras 2
JM - Giamaica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MY - Malesia 2
RO - Romania 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TW - Taiwan 1
Totale 3.681
Salva come PNG Salva come JPEG
Città #
Singapore 247
Chandler 162
Ashburn 134
Houston 75
Hefei 66
Beijing 53
New York 47
Redmond 45
Dublin 43
Kraków 42
Ho Chi Minh City 41
Hanoi 37
São Paulo 33
Jacksonville 32
Los Angeles 32
San Mateo 31
Jakarta 28
Boston 26
Cattolica 23
Hong Kong 23
Milan 23
Seoul 19
Wilmington 19
Kent 18
The Dalles 18
Tokyo 18
Nanjing 17
Rome 17
Frankfurt am Main 16
Brooklyn 13
Dallas 13
Seattle 13
Dearborn 12
Helsinki 12
Lawrence 12
Princeton 12
Buffalo 11
Nanchang 11
Chennai 10
Munich 10
Rio de Janeiro 10
Roubaix 10
Santa Clara 10
Chicago 9
Marseille 9
Mexico City 9
Poplar 9
Stockholm 9
Düsseldorf 8
Guayaquil 8
Haiphong 8
Montreal 8
Moscow 8
Norwalk 8
Redwood City 8
San Jose 8
Warsaw 8
Belo Horizonte 7
Bexley 7
Lappeenranta 7
Mumbai 7
Phoenix 7
Pune 7
Amsterdam 6
Ann Arbor 6
Hải Dương 6
Johannesburg 6
Nuremberg 6
Orem 6
Paris 6
Woodbridge 6
Ankara 5
Atlanta 5
Boardman 5
Brasília 5
Bremen 5
Brussels 5
Curitiba 5
Denver 5
Dhaka 5
Manaus 5
Monza 5
Portsmouth 5
Tashkent 5
Tianjin 5
Albuquerque 4
Hyderabad 4
London 4
Montevideo 4
Nürnberg 4
Ottawa 4
Quito 4
Rotonda 4
San Francisco 4
Tavagnacco 4
Turku 4
Vancouver 4
Vienna 4
Washington 4
Basra 3
Totale 1.880
Salva come PNG Salva come JPEG
Nome #
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 251
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 162
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort) 140
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 137
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 120
Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe 118
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons 117
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 117
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 115
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 114
Liver fibrosis progression and clinical outcomes are intertwined: Role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCVcoinfected patients with detectable HCV-RNA A MASTER cohort study 111
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 105
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 86
Natural NS5A inhibitor resistance associated substitutions in hepatitis C virus genotype 1 infected patients from Italy 82
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 78
A systematic review of dalbavancin efficacy as a sequential therapy for infective endocarditis 77
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors 77
Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy 74
Utility, acceptability and applicability of a nucleic acid amplification test in comparison with a syndromic approach in the management of sexually transmitted diseases at Mulago National Referral Hospital in Uganda (ASTRHA): Protocol for an open-label, randomised controlled trial 72
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience 71
Survival in HIV-infected patients after a cancer diagnosis in the cART era: Results of an Italian multicenter study 71
Real World Data from an Italian Outpatient Clinical Setting and from Home Care Assistance of Treatment-Experienced PWH Switching to CAB + RPV Regimen: A Prospective Observational Study 69
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 69
Prolonged survival in HIV-associated Progressive Multifocal Leukoencephalopathy treated with Pembrolizumab: a case series on treatment and long-term follow-up 68
Heteroresistance and clinical outcomes: knowledge gaps 67
Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response 67
Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received 66
The effect of primary drug resistance on CD4 cell decline and the viral load set-point in HIV positive individuals before the start of antiretroviral therapy 66
Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir: Results from clinical practice 64
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 63
Autochthonous dengue outbreak in Rome, Italy, in 2023 62
HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir 62
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 57
Treatment with valacyclovir during pregnancy for prevention of congenital cytomegalovirus infection: a real-life multicenter Italian observational study 56
Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort 56
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 55
HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure 53
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study 51
New advances in management and treatment of cardiac implantable electronic devices infections 49
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 49
Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19 48
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 47
Assessing dengue seroprevalence among people living with HIV (PLWH) in rome, Italy: Insights from the 2023 Italian autochthonous outbreak 45
Evolving phenotypes of non-hospitalized patients that indicate long COVID 43
Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis 41
What Every Reader Should Know About Studies Using Electronic Health Record Data but May Be Afraid to Ask 39
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 29
Totale 3.736
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.522
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 9 9 4 20 2 14 2
2021/2022164 6 9 1 6 7 4 11 30 7 7 36 40
2022/2023413 62 61 31 48 36 50 13 36 50 4 13 9
2023/2024219 10 54 1 15 4 39 13 11 3 4 42 23
2024/2025755 5 10 47 9 38 19 51 35 70 72 205 194
2025/20261.548 357 119 220 409 367 76 0 0 0 0 0 0
Totale 3.736